Podcasts about Insys

Insys was the startup unicorn of the opioid crisis, and boy did they know how to party.  Becca & Adam meet Insys CEO John Kapoor and his rowdy band of crooked pharmaceutical reps as they slither their way through doctors offices across the country, pushing their marquee product: Fentanyl! The shady sales reps unleashed the powerful opioid on unsuspecting patients and bribed their doctors to increase dosages through an illegal kickback scheme. Eventually their shameless conspiracies and criminal shakedowns lead to a public meltdown and federal racketeering charges, but not before Kapoor could be crowned Forbes coverboy!  CW: Drug abuse  Links:  Pictures on our Substack The Pain Hustlers - NYT Expose  Read Pain Hustlers - the book An Opioid Spray Showered Billionaire John Kapoor In Riches. Now He's Feeling The Pain A potent painkiller, and the drug maker's marketing, are faulted in a woman's death Pharmaceutical Executive John Kapoor Sentenced To 66 Months In Prison In Opioid Trial Tracking the Opioid Settlement Cash

Neste episódio especial do Voz Afro, mergulhamos na fascinante jornada de Rezzito, o talentoso criador de conteúdo digital. De experiências de vida transformadoras a conquistas na carreira, exploramos as nuances de sua trajetória única. Descubra os bastidores de suas criações digitais, os desafios superados e as inspirações que moldaram sua voz autêntica. Uma conversa envolvente que revela a interseção entre identidade afro e presença digital, destacando a importância de contar histórias autênticas e criar conexões significativas. Prepare-se para uma imersão na vida e mente criativa de Rezzito, onde cada palavra é uma expressão vibrante de sua narrativa inspiradora. Siga o Rezzito no Instagram: https://www.instagram.com/rezzito/ ================================================= Este episódio conta com o apoio do Denga Love, um aplicativo de relacionamento exclusivo para pessoas pretas. Quer desfrutar de 30 dias de acesso VIP gratuito no Denga? Faça o download do aplicativo agora mesmo e utilize o código promocional VOZAFRO para vivenciar o amor preto em toda a sua essência. Não perca tempo, clique no link abaixo e baixe o app: https://dengalove.com/ ================================================= O Banco Afro em parceria com Insys, fez essa campanha especialmente para a galera das classes C, D e E. Queremos que todo mundo tenha acesso a uma tecnologia bacana sem gastar muito. Acreditamos que todo mundo merece aproveitar a tecnologia, independentemente da grana, e essa campanha é nosso jeito de garantir isso. Para saber mais, acesse: https://bancoafro.com.br/lp/insys/ ================================================= Siga o Voz Afro nas redes sociais: Instagram: https://instagram.com/podcastvozafro Tiktok: https://tiktok.com/@vozafro

Neste episódio especial do Podcast Voz Afro, vamos mergulhar na inspiradora trajetória do talentoso ator Reinaldo Junior. De origens a desafios, vamos falar como Reinaldo superou obstáculos, encontrou sua voz no mundo artístico e se tornou um agente de empoderamento para a comunidade negra. Uma conversa autêntica, repleta de insights sobre representatividade, resiliência e a importância de contar histórias que reverberam a diversidade. Vem com a gente nesta jornada única, enquanto desvendamos os bastidores da carreira de Reinaldo Junior e celebramos a força da Voz Afro no cenário cultural contemporâneo. Siga o Reinaldo no Instagram: https://www.instagram.com/reiblack ================================================= O Banco Afro em parceria com Insys, fez essa campanha especialmente para a galera das classes C, D e E. Queremos que todo mundo tenha acesso a uma tecnologia bacana sem gastar muito. Acreditamos que todo mundo merece aproveitar a tecnologia, independentemente da grana, e essa campanha é nosso jeito de garantir isso. Para saber mais, acesse: https://bancoafro.com.br/lp/insys/ ================================================= Siga o Voz Afro nas redes sociais: Instagram: https://instagram.com/podcastvozafro Tiktok: https://tiktok.com/@vozafro

Welcome to the Daily Compliance News. Each day, Tom Fox, the Voice of Compliance, brings you compliance-related stories to start your day. Sit back, enjoy a cup of morning coffee, and listen in to the Daily Compliance News. All from the Compliance Podcast Network. Each day, we consider four stories from the business world: compliance, ethics, risk management, leadership, or general interest for the compliance professional. Stories we are following in today's edition: Bringing HR into the modern era. (WSJ) Geopolitical volitivity. (FT) Doctor charged with taking kickbacks from Insys settles. (Reuters) Myanmar steps up anti-corruption crackdown. (NikkeiAsia) Learn more about your ad choices. Visit megaphone.fm/adchoices

How does a school guidance counselor go on to generating over $3 billion dollars of sales in the pharmaceutical drug industry? Meet Alec Burlakoff who was the VP of sales at Insys Pharmaceuticals. You may have seen him on 60 minutes, maybe you have read his book "Selling Hard Lessons Learned." Netflix has a movie coming out about in October titled "Pain Hustlers." In the end the founder and 6 company executives were convicted. It was one of the first of its kind taking down executives with prison sentences in the pharmaceutical C-Suite. This is a fascinating story of a man that was told by his Dad he wanted Alec to avoid sales, so Alec got a masters in child psychology and became a guidance counselor and coach at a prestigious private school. One of the parents told Alec that he could get him an interview at Eli Lilly. Alec wanted to make more money and went to the interview and became the Rookie of the Year at Eli Lilly. He made a name for himself then jumped to Johnson and Johnson before he landed at InSys. Alec is a man who is straight forward and honest about what he did and how he did it. He also gives us a behind the scenes look of doing your prison time during COVID. This is an incredible rollercoaster story. You won't want to miss this one.

Welcome to "The Wolf Den," in this episode we venture into the heart of the American opioid epidemic, exposing the dark underbelly of pharmaceutical sales and the devastating impact it has had on countless lives. In this special feature, we invite you to join us for an exclusive and emotionally charged interview with Alec Burlakoff, a former top executive at Insys Therapeutics. As we unravel the shocking details, brace yourself for Burlakoff's candid revelations, which lay bare the unethical practices that fueled the crisis. Insys Therapeutics, the Arizona-based manufacturer of the powerful opioid painkiller Subsys, faced bankruptcy after a groundbreaking criminal case brought to light a reckless conspiracy to illegally boost profits from the drug. Burlakoff, along with other executives, faced prison sentences, marking a significant turning point in holding pharmaceutical leaders accountable for their role in the epidemic. Join us as we delve into Burlakoff's tumultuous journey at Insys Therapeutics. Driven by personal struggles with illness and depression, Burlakoff initially sought to make a positive impact in the pharmaceutical industry. However, he found himself entangled in a ruthless world where success often came at the expense of moral integrity. In this emotionally charged interview, Burlakoff unveils the aggressive tactics employed to justify the sales of opioids, even amid legal controversies surrounding their marketing. His insider account paints a chilling picture of the unscrupulous practices that permeated the pharmaceutical industry during his tenure at Insys. Throughout the conversation, Burlakoff doesn't shy away from confronting his own culpability, acknowledging the insidious nature of greed and its impact on ethical decision-making. His raw and heartfelt introspection offers listeners a rare glimpse into the moral dilemmas faced by those within the pharmaceutical world. "The Wolf Den" doesn't just shed light on the devastation caused by the opioid crisis; it also raises crucial questions about the accountability of pharmaceutical executives and the role of regulatory bodies like the FDA. Burlakoff's emotionally charged testimony serves as a powerful reminder of the urgency for transparency, ethical conduct, and compassionate healthcare practices. Join us for a riveting exploration of the opioid epidemic and the individuals who played a part in perpetuating it. "The Wolf Den" presents this thought-provoking interview, encouraging us all to confront the harsh realities and seek meaningful solutions to combat the opioid crisis affecting communities nationwide. Get ready for an impactful journey that will leave a lasting impression on your understanding of this critical issue. Show Links  Narcotics Anonymous  https://www.na.org/

Alec Burlakoff was the VP of sales at Insys Therapeutics. The first pain management company to ever face criminal charges for it's illegal sales of their fentanyl product, Subsys. Alec Burlakoff served 26 months in federal prison for his role in the company. We talked about how he got into pharmaceutical sales, his life during his time at Insys and his hopeful road to redemption. For a free copy of Alec's book - email him at training@aburlakoff.com Alec's Book: https://www.amazon.com/Selling-Lessons-Learned-Alec-Burlakoff/dp/B0BCSGPYS2/ref=sr_1_2?crid=1OMTF8VNYEL4T&keywords=Alec+Burlakoff&qid=1663173596&sprefix=%2Caps%2C342&sr=8-2 0:00 Intro0:40 Who is Alec Burlakoff 4:00 How Alec got into sales 8:40 Doctors Alec targeted 14:40 Pain management companies doing jail time 21:15 Why Alec is a good salesmen 28:15 Have Alec's daughters seen what he's done 32:40 Being #1 and the rat race 44:15 Alec's lifestyle during his time selling opiods. Coke. Strip Clubs 48:00 Netflix movie based on Alec's life 56:15 How to stop being Pharma

In 1920, the US began recording deaths from Opioids; between 1920 and 1921, 105 people died from accidental overdose.In 2021, 80,816 people died from overdose on opioids (CDC). We are losing a battle. The opioid crisis is a healthcare system problem; one component of this system is the sales rep. In this episode, we interview Alec Burlakoff. Alec was the VP for sales at Insys and a master of sales and building teams. His skills, contributed to explosive sales of Fentanyl and current crisis. Alec joins Leslie and I, so we begin to understand how we each parts of healthcare contributed to the crisis. We discuss sales and Alec shares about his life and work. To learn more about Alec's current work, see his sites:Limitless! Sales Coaching  https://course.aburlakoff.com/homeSCHEDULE FREE 20 minute Consult https://bit.ly/3WEunxw

We are back with season 9 and we decided to ease our way in with a fun light hearted... jk this one is depressing. Despite some sidetracks into discussing doctor jail, we talk about John Kapoor and his pharmaceutical company Insys Therapeutics, who created one of the first oral sprays of a new drug to help fight against pain in late stage cancer patients. However, when sales weren't hitting targets John Kapoor and Insys proceeded with quite a few shady dealings to increase the use of their new drug, Fentanyl, kicking off the now rampant opioid epidemic.

Hey Q Crew! This week we conclude our deep dive into the company called “Worse Than Theranos” by New York Magazine. Insys Therapeutics. Our main sources are the fabulous book by Evan Hughes called “The Hard Sell: Crime and Punishment at an Opioid Startup” and The New York Magazine article linked below. In this final episode we cover the “whales” that double, triple, and quadruple dipped in this whole scheme, the downfall of the company, and the arrogance of its leadership. Links referenced in this episode: New York Magazine: https://nymag.com/intelligencer/2022/01/worse-than-theranos.html Theranos Playlist: https://youtube.com/playlist?list=PLx_q6cCrV0AEdl3IQuybQafKU2WIwwNql Enron Playlist: https://youtube.com/playlist?list=PLx_q6cCrV0AEhGk-GqyMytEcwNpFHQ6_k Money & Murder w/ Lara Mack-Downfall: The Case Against Boeing: https://youtu.be/_bt2vs3tmfI Keep sending you stories, deep dive topics, and questions to qasincucumber@yahoo.com. Don't forget to like and subscribe and all that jazz on iTunes or your favorite podcasting platform! Enjoy! Love your faces, Lara Social Media Links: Youtube: https://www.youtube.com/c/LaraMackPodcasts Facebook: https://www.facebook.com/QasinCucumber Instagram: https://www.instagram.com/qaic_lara/?hl=en       https://www.instagram.com/qaic_tanya/?hl=en Twitter: https://twitter.com/qaic_lara  https://twitter.com/qaic_tanya Podbean: https://qasincucumber.podbean.com/ #insys #fentanyl #subsys #thehardsell #evanhughes #audible #theranos #elizabethholmes #sunnybalwani #thedropout #commentary #podcast #comedypodcast #entertainment #scandal     Theranos Part 1 https://www.podbean.com/ew/pb-q8s49-b987da Theranos Part 2 https://www.podbean.com/ew/pb-2nics-ba77f3 Theranos Part 3 https://www.podbean.com/ew/pb-dzpt4-bbd87f Updates https://www.podbean.com/ew/pb-vg6gd-ff1067 https://www.podbean.com/ew/pb-247ei-104edbc https://www.podbean.com/ew/pb-ghjpb-1088877 https://www.podbean.com/ew/pb-s4bse-106c1ed https://www.podbean.com/ew/pb-9uaqi-10d1b20 https://mcdn.podbean.com/mf/web/rx9bte/Cornfuzzled.mp3 https://www.podbean.com/ew/pb-tiq9t-10f51c8 https://www.podbean.com/ew/pb-bfdnb-10feaec https://www.podbean.com/media/share/pb-s4bse-106c1ed https://www.podbean.com/ew/pb-cqnnd-1107f3a https://www.podbean.com/ew/pb-dptav-1112012 https://www.podbean.com/ew/pb-p9ze6-1132ebc https://www.podbean.com/ew/pb-gkj58-114c701 https://www.podbean.com/ew/pb-bsiyx-1157f4b

Hey Q Crew! This week we continue with our deep dive into the company called “Worse Than Theranos” by New York Magazine. Insys Therapeutics. Our main sources are the fabulous book by Evan Hughes called “The Hard Sell: Crime and Punishment at an Opioid Startup” and The New York Magazine article linked below. In this second episode we cover how the 4 Horseman finally come together and begin their criminal journey. They launched Subsys into the market and created addicts by bribing doctors and scamming insurance companies. Make sure to subscribe so you don't miss the conclusion! Links referenced in this episode: New York Magazine: https://nymag.com/intelligencer/2022/01/worse-than-theranos.html Theranos Playlist: https://youtube.com/playlist?list=PLx_q6cCrV0AEdl3IQuybQafKU2WIwwNql Money & Murder w/ Lara Mack-Downfall: The Case Against Boeing: https://youtu.be/_bt2vs3tmfI Keep sending you stories, deep dive topics, and questions to qasincucumber@yahoo.com. Don't forget to like and subscribe and all that jazz on iTunes or your favorite podcasting platform! Enjoy! Love your faces, Lara Social Media Links: Youtube: https://www.youtube.com/c/LaraMackPodcasts Facebook: https://www.facebook.com/QasinCucumber Instagram: https://www.instagram.com/qaic_lara/?hl=en       https://www.instagram.com/qaic_tanya/?hl=en Twitter: https://twitter.com/qaic_lara  https://twitter.com/qaic_tanya Podbean: https://qasincucumber.podbean.com/ #insys #fentanyl #subsys #thehardsell #evanhughes #audible #theranos #elizabethholmes #sunnybalwani #thedropout #commentary #podcast #comedypodcast #entertainment #scandal

Hey Q Crew! This week we start our deep dive into the company called “Worse Than Theranos” by New York Magazine. Insys Therapeutics. Our main sources are the fabulous book by Evan Hughes called “The Hard Sell: Crime and Punishment at an Opioid Startup” and The New York Magazine article linked below. In this first episode we cover a little history of the drug at the center of all this- Subsys. Which is an under the tongue fentanyl spray designed for “break through cancer pain”. However, it was mostly used by pain management doctors who were bribed by Insys to push it to their patients and turn them into addicts. We close out by getting to know the main players: John Kapoor, Michael Babich, Matthew Napoletano, and Alec Burlakoff. The 4 Horseman of the Apocalypse. Make sure to subscribe so you don't miss parts 2 and 3! Links referenced in this episode: New York Magazine: https://nymag.com/intelligencer/2022/01/worse-than-theranos.html Theranos Playlist: https://youtube.com/playlist?list=PLx_q6cCrV0AEdl3IQuybQafKU2WIwwNql Money & Murder w/ Lara Mack-Downfall: The Case Against Boeing: https://youtu.be/_bt2vs3tmfI Keep sending you stories, deep dive topics, and questions to qasincucumber@yahoo.com. Don't forget to like and subscribe and all that jazz on iTunes or your favorite podcasting platform! Enjoy! Love your faces, Lara Social Media Links: Youtube: https://www.youtube.com/c/LaraMackPodcasts Facebook: https://www.facebook.com/QasinCucumber Instagram: https://www.instagram.com/qaic_lara/?hl=en       https://www.instagram.com/qaic_tanya/?hl=en Twitter: https://twitter.com/qaic_lara  https://twitter.com/qaic_tanya Podbean: https://qasincucumber.podbean.com/ #insys #fentanyl #subsys #thehardsell #evanhughes #audible #theranos #elizabethholmes #sunnybalwani #thedropout #commentary #podcast #comedypodcast #entertainment #scandal

Marc Cohodes has earned a living and a reputation betting against companies he suspects committing fraud. His high-profile take-downs include Insys Therapeutics founder John Kapoor—the orchestrator of a scheme to bribe doctors to prescribe a fentanyl-based pain medication that caused the deaths of 7,000 people.  During our earthy and entertaining chat, Cohodes' describes how his shorting career began when he bet against a pinball machine manufacturer at the dawn of the video game age. He explains the rationale behind some of his long positions and maintains that it's not what you've done but what you do next that counts.

VPN | FEHLERMELDUNGEN | ZUSTÄNDE | URSACHEN | www.iotusecase.comEgal ob Fräsen, Bohren, Drehen, Senken, Reiben, Gewinden, Sägen - Service steht bei Herstellern an erster Stelle! Die 54. Folge des IIoT Use Case Podcast dreht sich um neue, smarte (Kunden-)Services im Verarbeitenden Gewerbe, die durch herstellerunabhängige Router- und Gateway-Connectivity ermöglicht werden. Lösungsgeber ist die Firma INSYS, ein langjähriger Experte für sichere Kommunikation und Vernetzung von Maschinendaten aus der Ferne. Anwender der im Podcast vorgestellten INSYS-Komplettlösung ist die CHIRON Group – bekannt als global agierender Spezialist für CNC-gesteuerte Fräs- und Drehbearbeitungszentren. Im Use Case geht es um neue Services, die CHIRON den Abnehmern ihrer Maschinen und Geräte mithilfe von Fernwartung und IIoT bereitstellt. Die Ziele sind dabei ganz klar: mehr Kundennähe aufbauen und Distanzen verringern, Anlagenverfügbarkeit erhöhen und Maschinenproduktivität sicherstellen, vorausschauende (Fern-)Wartung ermöglichen, schnellere Reaktion auf unvorhersehbare Störungen und damit Stillstandzeiten verringern. Wichtige Stichworte dieser Podcastfolge: Router, Gateways, Device Management und Condition Services.Stellvertretend für die beiden teilnehmenden Firmen begrüßt Gastgeberin Madeleine Mickeleit zwei Experten auf ihrem Gebiet: Daniel Fritz, Head of Key Account Management bei der Firma INSYS icom und Johannes Strobel, Service-Spezialist der CHIRON Group.Welche Herausforderungen es im konkreten Use Case gibt, wie diese bewältigt werden und wie die Lösung in der Praxis genau funktioniert – das gibt's in dieser Podcastfolge zu hören.(Gastgeberin | https://www.linkedin.com/in/madeleine-mickeleit/)(Interviewpartner | https://www.linkedin.com/in/daniel-fritz-587a291a0/ )

Episode Notes------------------Fraud in America Social Links

RMA-Episode 40 Show Notes:   If you thought Perdu Pharma was the real villain behind the opioid epidemic, let me introduce you to Insys Therapeutics. A pharmaceutical company run by the disgraced and imprisoned CEO John Kapoor, Insys broke new ground when it came to using sleazy sales tactics to get greedy doctors to write bogus prescriptions for their fentanyl lollipops and sublingual spray.  When the DEA started to crack down on companies like Insys and the pill mills that popped up overnight in the southern United States, the pharmaceutical companies lobbied Congress and had the law changed, paving the way for years of legal drug-dealing by some of the richest men in America. This week on Recovery in the Middle Ages, Mike and Nat continue their review of the new HBO documentary The Crime of the Century, a searing indictment of Big Pharma and the political operatives and government regulations that enable over-production, reckless distribution, and mass abuse of synthetic opiates.   Of course, we also have the weekly wrap-up, Recovery in the News and the Week in Weird on a painless, easily influenced by suitcases full of cash and unexplainable by ordinary physics episode of Recovery in the Middle Ages   The Crime of the Century   Patrick Radden Keefe   Empire of Pain: The secret History of the Sackler Dynasty   Free Beer for Covid Vaccine Target Being Met   The Truth is Out There   LISTEN TO RMA ON YOUTUBE PLEASE leave us a 5 star review on I-Tunes if you're enjoying the show and SUBSCRIBE to get the latest episodes.  You can reach us by email at: MikeR@middleagesrecovery.com Natx@middleagesrecovery.com   Send comments, complaints, death threats, ideas and requests to be interviewed. We'll talk to anyone! Check out the website: Www.middleagesrecovery.com   Visit MiddleAgesRecovery.com and tell us your story of your struggles with alcohol and drugs. Fill out the “tell us your story” Form on the website, write your recovery or using story and we will read it on the air! (Anonymity guaranteed).   FOLLOW US ON TWITTER  Join the Facebook Page! Exciting things are happening there!   We also have a Facebook Group! Request to join the group. It's a private space for continuing the discussion of what Nat and Mike talk about on the podcast. Hope to see you there. If you're in trouble with substance abuse and need help, reach out. There are thousands of people who have put problems with addiction in their rear-view mirrors and you can be one of them. While we neither endorse nor condemn any particular program, the sheer number of available AA and NA meetings suggest that reaching out to those organizations would be a good first step on the road to recovery.     https://www.aa.org/ https://www.na.org/meetingsearch/   Marijuana Anonymous (just in case):   This Naked Mind

How a drug company made millions pushing an opioid painkiller up to 100x stronger than heroin, as many on Wall Street looked the other way. FRONTLINE filmmaker Tom Jennings and Financial Times reporter Hannah Kuchler discuss their new investigation of Insys Therapeutics — from a jaw-dropping interview with a former sales director who admits to bribing doctors to prescribe the highly addictive drug Subsys, to how Wall Street propelled Insys’ success even as questions emerged about its practices, to what role drug companies’ pursuit of profits has played in the opioid crisis: “I think that it's really interesting just how people are able to disconnect their actions from the consequences, especially in business,” Kuchler says. With federal prosecutors using laws designed to catch mob bosses, Insys would ultimately become the first pharmaceutical company to have its top executives sentenced to prison time in connection with the opioid epidemic. For more on Insys’ spectacular rise and fall — and its consequences — watch the documentary Opioids, Inc. from FRONTLINE and the FT, and read our in-depth joint reporting — also available at ft.com/insys.

How a drug company made millions pushing an opioid painkiller up to 100x stronger than heroin, as many on Wall Street looked the other way. FRONTLINE filmmaker Tom Jennings and Financial Times reporter Hannah Kuchler discuss their new investigation of Insys Therapeutics — from a jaw-dropping interview with a former sales director who admits to bribing doctors to prescribe the highly addictive drug Subsys, to how Wall Street propelled Insys’ success even as questions emerged about its practices, to what role drug companies’ pursuit of profits hasplayed in the opioid crisis: “I think that it's really interesting just how people are able to disconnect their actions from the consequences, especially in business,” Kuchler says. With federal prosecutors using laws designed to catch mob bosses, Insys would ultimately become the first pharmaceutical company to have its top executives sentenced to prison time in connection with the opioid epidemic. For more on Insys’ spectacular rise and fall — and its consequences — watch the documentary Opioids, Inc. from FRONTLINE and the FT, and read our in-depth joint reporting — also available at  ft.com/insys.

Executives from drugmaker Insys were the first from the pharmaceutical sector to be handed prison time for their role in America’s opioid epidemic earlier this year. The FT and the PBS series Frontline have investigated why the warning signs around the company were ignored for so long. FT pharmaceutical correspondent Hannah Kuchler tells Marc Filippino what they uncovered.Read the story at ft.com/insys.The PBS Frontline documentary, Opioids, Inc. is available for streaming online at PBS.org beginning Friday June 19, and will premiere on American PBS stations on Tuesday, June 23. For more information visit: https://www.pbs.org/wgbh/frontline/film/opioids-inc/. See acast.com/privacy for privacy and opt-out information.

Gerald Leo Posner (born May 20, 1954) is an investigative journalist, author and former Wall Street attorney. A native of San Francisco, CA, Posner was a Phi Beta Kappa and Summa Cum Laude graduate of the University of California at Berkeley (1975). He was also a national debating champion at this time, winning the Meiklejohn Award. Posner went on to receive a JD from UC Hastings, Berkeley. Perhaps most notably of yet, is his New York Times bestselling book: Case Closed: Lee Harvey Oswald and the Assassination of JFK (1993), which digs into the John F. Kennedy assassination. Gerald followed that up with the book: Killing the Dream: James Earl Ray and the Assassination of Martin Luther King, Jr. (1998). In 2015 Posner released: God's Bankers: A History of Money and Power at the Vatican. This work became Posner's third NY Times Bestseller. "A merciless pitbull of an investigator." Chicago Tribune Gerald's latest book PHARMA: Greed, Lies and the Poisoning of America eyes corrupt corporate American pharmaceuticals. Listed in 2016 as #52 of Deloitte's "Fast 500 North America", one such company that comes under Posner's fire is Insys (Phoenix, AZ). Maker of Subsys, a sublingual liquid form of fentanyl, the company declared bankruptcy (Delaware) in 2019. Former VP of sales, Alec Burlakoff, was accused of operating a program that paid doctors lucrative "speaking fees" to encourage prescriptions of the drug and in 2017, Insys founder John Kapoor had been charged with RICO conspiracy and conspiracy to violate the Anti-Kickback Law. Posner regularly contributes to NBC, the History Channel, CNN, FOX News, CBS, and MSNBC. He is a member of the NY and DC bars as well as the International Criminal Court. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/iantrottier/support

Jan 27: Avenatti jury selection in #SDNY, US v Schulte CIA leaks press access, Insys doc 57 months for sleaze like China-bought UNSG @AntonioGuterres silent on #Coronavires

Last week was a very busy week for the DOJ and our criminal courts who laid down multi-year criminal jail sentences to Insys execs for their role in a bribery scheme behind selling their potent fentanyl-based opioid, Subsys, and a $17.5 million dollar fine upon Wells Fargo's former exec behind their fake-account scheme discovered in 2016. Is corporate corruption finally seeing some accountability?

President Trump mentioned taking a look at cuts to Social Security. We discuss the implications and how the issue of Social Security, Medicare, and Medicaid are showing up in the presidential race. Trump’s White House is also rolling out a new rule to limit so-called “birth tourism.” We discuss what this could mean for literally any woman applying for a visitor visa.  And in headlines: pharma exec goes to jail for Insys, special clocks, and NYC goes cashless-less.

In February of 2019, we interviewed Palm Beach Post reporters Pat Beall and John Pacenti, about the trial of former executives from opioid manufacturer Insys Therapeutics. They’d been accused of racketeering, bribing doctors to prescribe their high-powered opioid fentanyl spray, Subsys, to patients who didn’t need it. A year later, the Insys executives have finally received sentences of 1 to 5 ½ years in prison. This is the first time big pharma execs have been convicted and sent to prison for racketeering. It’s arguable whether this sentence achieves justice for the 900-plus lives lost to opioid addiction that began with Subsys prescriptions. But, it does send a clear message to the rest of the pharmaceutical industry. To share their insight into the Insys sentencing, Palm Beach Post reporters, John Pacenti and Pat Beall return to the podcast. Together, we break-down what this case means for the rest of the pharmaceutical industry and the questions that remain.

Kapoor was accused of masterminding a scheme to bribe doctors to prescribe more addictive opioids. WBZ NewsRadio's Madison Rogers reports.

A powerful rebound in Intel’s data centre division drove a stronger than expected recovery in the final quarter of 2019, former Wells Fargo chief executive John Stumpf has agreed to pay $17.5m as part of a settlement with US regulators over the bank’s fake accounts scandal, and the European Central Bank begins its first strategic review in 16 years. Plus, the founder of the opioid maker Insys has been sentenced to five-and-a-half years in prison. The FT’s Hannah Kuchler explains what this means for other US pharmaceutical executives. See acast.com/privacy for privacy and opt-out information.

Today, two former execs for Insys Therapeutics, a player sued in the opioid litigation, were sentenced to jail for their role in a kickback and bribery scheme using doctors to sell their highly-potent fentanyl opioid, Subsys. We disect the sentences, the drug behind them, and the outlook for other executives as the opioid litigation continues.

Michael Babich and Sunrise Lee, two Insys Therapeutics executives, were sentenced in Boston Federal Court for participation in a scheme to push addictive opioid prescriptions. WBZ NewsRadio's Shari Small reports.

After seven pharmaceutical executives were found guilty of bribing doctors to prescribe their fentanyl spray to cancer patients, a hearing concerning the issue of restitution was held in Federal Court in Boston Monday morning. WBZ NewsRadio's Kim Tunnicliffe reports.

Seven pharmaceutical executives were found guilty of bribing doctors to prescribe their fentanyl spray to cancer patients who didn't need it. The first of them was sentenced Monday, and a hearing was also held on restitution for the victims of their scheme. WBZ NewsRadio's Kim Tunnicliffe reports.

Opioid drugmakers Insys Therapeutics and Mallinckrodt Pharmaceuticals face millions of dollars in settlement as a consequence of allegedly bribing doctors to prescribe their drugs.

Roddy Boyd heads up the Southern Investigative Reporting Foundation. On today's podcast, we talk about the massive story on Insys that he broke and why there's no more investigative reporting in financial media. Roddy on Twitter is: @RodBoydILM and @SIRF_Report www.sirf-online.org QTR Podcasts are always free, but some people choose to make a small recurring donation, which is gratefully accepted: https://www.patreon.com/QTRResearch   Donations of $100 or more can also be sent via: Bitcoin: 3G25NvNbGZsaDfoxTBzRFticKa4LDUeBpk Venmo: @chrisinphiladelphia Paypal: christopher.d.irons@gmail.com   THANK YOU TO ALL OF MY KIND PATRONS   Please show love to those who support the QTR Podcast.    Biggest Patron Donors    The Trader's Path - no BS trading service - Twitter: @PLHStock RumorHound.ai - free 14 day trial - Twitter: @RumorHound Sang Lucci Trading - read tape & learn flow Master Course  HeliBacon - shoot machine guns from helicopters in Texas Corvus Gold - http://www.corvusgold.com "Piggly Wiggly" Investors Underground - day trading community - Twitter: @investorslive  Chris Boas  Ken R  Chris Bede - Twitter: @cbede  Nicholas Parks Matthew Zimmer Russ Valenti - Twitter: @russellvalenti  Longest Running Supporters   Max Mulvihill - Since 2/2018  Kyle Thomas - Since 4/2018  Chris Bede - Since 5/2018  Dariusz Kordonski - Since 5/2018  Chris Gerrard - Since 5/2018    All podcast content is subject to this disclaimer.    Chris is not an investment adviser. Listeners should always speak to their personal financial advisers.     THIS IS NOT INVESTMENT ADVICE - OPINION ONLY AND FOR JOURNALISTIC AND DISCUSSION PURPOSES 

Friday June 21, 2019 Insys Gets Prosecution Deferred to Pay $225 Million

Drug manufacturers who face large settlements from the opioid crisis could follow the Insys example and file for bankruptcy protection experts say. See acast.com/privacy for privacy and opt-out information.

Drug manufacturers who face large settlements from the opioid crisis could follow the Insys example and file for bankruptcy protection, experts say.

Drug manufacturers who face large settlements from the opioid crisis could follow the Insys example and file for bankruptcy protection, experts say.

In today’s edition of Daily Compliance News:Senegal justice ministry calls for inquiry into energy contracts. (Reuters)Convicted opioid pusher Insys files for bankruptcy. (NYT)Trump said he was “a little bit concerned” about Raytheon/United Technologies merger. (Washington Post)Will California strengthen its data protection laws? Not if Big Tech can help it. (Bloomberg) Learn more about your ad choices. Visit megaphone.fm/adchoices

In today’s edition of Daily Compliance News: ·  Insys execs found guilty of racketeering. (New York Times)    Is a socialist revolt coming? (New York Times)·       What’s the going rate for paying BB players at Arizona? Apparently as high as $10K per month. (ESPN)·       Where goeth Tesla? Hat in hand looking for cash apparently. (Wall Street Journal) Learn more about your ad choices. Visit megaphone.fm/adchoices

In today’s edition of Daily Compliance News: ·  Insys execs found guilty of racketeering. (New York Times)    Is a socialist revolt coming? (New York Times)·       What’s the going rate for paying BB players at Arizona? Apparently as high as $10K per month. (ESPN)·       Where goeth Tesla? Hat in hand looking for cash apparently. (Wall Street Journal) Learn more about your ad choices. Visit megaphone.fm/adchoices

Investors flock back to a complex debt-derivatives product blamed for amplifying losses in the financial crisis, thousands of US screenwriters take on their private equity-backed agents, and the billionaire founder of drugmaker Insys is among those found guilty of bribing doctors to prescribe an addictive painkiller. Plus, the FT’s banking editor David Crow explains what is next for Barclays after activist investor Edward Bramson suffered a heavy defeat in his bid for a seat on the investment bank’s board. See acast.com/privacy for privacy and opt-out information.

In episode #46, Krishn & Joanne discuss a range of topics including: The importance of phytonutrients & biodiversity in food. Recent lawsuits involving unethical practices used by Perdue Pharma and Insys that helped to fuel North America's opioid crisis. Resources: Eating on the Wild Side, Jo Robinson Oxycontin Family Made Billions On Opioid As Crisis Raged, CTV The Opioid Crisis Hit Barrie Ont With A Painful Shock, Globe & Mail  

We frame today’s podcast with Palm Beach Post reporters, John Pacenti and Pat Beall with a clip from the Insys Therapeutics rap video on the virtues of persuading doctors to prescribe higher doses of the company’s liquid opioid, Subsys. This week jurors in the Insys racketeering case in Boston heard the following lyrics from the company’s self-produced video; “I love titration. Yeah, it’s not a problem. I got new patients and I got a lot of ‘em”. That may be the most damning evidence against former executives of the company yet. In this second part of our series, we continue our conversation on the deceptive sales practices pioneered by Purdue Pharma more than 20 years ago, and perpetuated by others in the industry. In 2007, Purdue Pharma executives pled guilty to misbranding and deceptive marketing but the charges were reduced from felonies to misdemeanors and they were sentenced to just 300 hours of community service, thanks in part to Rudy Giuliani. In January, the trial began for former executives of Insys Therapeutics for essentially the same deceptive sales practices Purdue Pharma pled guilty to 12 years earlier. Palm Beach Post reporter, John Pacenti describes a corrupt operation willing to do almost anything to induce physicians to overprescribe their product, Subsys Fentanyl spray. We close today’s podcast with more of the self-produced Insys rap video on the virtues of persuading doctors to prescribe higher doses of Subsys. Go to Cover2.org to view the entire video featuring the company’s former director of sales, Alec Burlakoff, in a giant prescription bottle.

This week on Young Bucks we discuss Paul Manafort's indictment, Constellation Brands investing into cannabis manufacturer Canopy Growth, and Ben calls out John Kapoor of Insys for his indictment on racketeering, among other things.Follow us on Twitter:https://twitter.com/TuskMediaLLCPlease see disclosures.

This week on Young Bucks we discuss Paul Manafort's indictment, Constellation Brands investing into cannabis manufacturer Canopy Growth, and Ben calls out John Kapoor of Insys for his indictment on racketeering, among other things.Follow us on Twitter:https://twitter.com/TuskMediaLLCPlease see disclosures.

I take another stab at last week's opioid news. Detailing the arrest of a massive purveyor of that drug, CEO of INSYS, John Kapoor is seemingly off to jail for trafficking. Might be good news for other demons in the same game. Our guest, Dawn Mcilmoyle is a former member of Canada's Navy and MST survivor. What is MST? Military Sexual Trauma… an American term that Canadian Military sufferers also use. And if they're naming it as a phenomenon, you know it's something that shouldn't be happening. Dawn tells us as much as she can share of her deep trauma in the military, and her long way out of it – using her green friend, cannabis.

1) AAN guideline summary: Treatment of restless legs syndrome in adults 2) What's Trending: Interview with Dr. Steven Messé on why acute ischemic stroke patients are not receiving IV tPA3) Topic of the month: Neurology Today story about cases of acute flaccid myelitis spike: What the Center for Disease Control says you should look out forThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michelle Fullard interviews Dr. John Winkelman about the AAN guideline summary on the treatment of restless legs syndrome in adults. Dr. Andy Southerland is interviewing Dr. Steven Messé for our “What's Trending” feature of the week about his paper on why are acute ischemic stroke patients not receiving IV tPA. In the next part of the podcast Dr. Ted Burns interviews Drs. Kevin Messacar and Ken Tyler about a Neurology Today story on the topic on cases of acute flaccid myelitis spike: What the Center for Disease Control says you should look out for.DISCLOSURES: Dr. Winkelman serves as Associate Editor for Sleep; serves as an editorial board member of Sleep Medicine and CNS Drugs; received honoraria from serving on the scientific advisory board of Merck Serono, Flex Pharma, UCB, Impax Pharmaceuticals, Pfizer Inc, Lacrima, Luitpold Pharmaceuticals, GlaxoSmithKline, Boehringer Ingelheim, Xenoport, Zeo Inc., Sunovion, Insys, Takeda Pharmaceutical Company Limited, Jazz and Neurogen; receives royalties from the publication of the books: Foundations of Psychiatric Sleep Medicine and Nocturnal Leg Cramps; holds stock options in Flex Pharma; provided expert witness work for ArentFox and CantorColburn; received funding for travel from Novartis and Otsuka; currently performs neurophysiology studies as part of his practice;receives research support from Xenoport, GlaxoSmithKline, UCB, Sepracor, Pfizer Inc, Impax Pharmaceuticals, Purdue, Neurometrix and the NIH.Dr. Southerland serves as Podcast Deputy Editor for Neurology; receives research support from the American Heart Association-American Stroke Association National Clinical Research Program, American Academy of Neurology, American Board of Psychiatry and Neurology, Health Resources Services Administration and the NIH; has a provisional patent application titled: “Method, system and computer readable medium for improving treatment times for rapid evaluation of acute stroke via mobile telemedicine;” and gave legal expert review.Dr. Messé received publishing royalties from UpToDate; received compensation from GlaxoSmithKline for consulting on protocol development for a trial of a neuroprotectant in high risk surgery; received research support from GlaxoSmithKline, Bayer Schering Pharma, WL Gore and the NIH.Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc.Dr. Tyler serves as an Associate Editor for Journal of Neurovirology and Neurology Today; serves as an editorial board member for Annals of Neurology, Apoptosis, JAMA Neurology, Experimental Neurology, Journal of Infectious Disease, Microbial Pathogenesis, Virology, Neurology ALL Current; serves on the scientific advisory board for PML Consortium; is a consultant for Hoffman La Roche; receives royalties from the publication of the books: Handbook of Clinical Neurology and Harrison's Principles & Practices of Internal Medicine; receives research support from the NIH. All other participants report no disclosures.